Koers Lonza Group AG Swiss Exchange
Aandelen
CH0013841017
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
||
480,2 CHF | 0,00% |
14/05 | Zwitserse beursindex loopt op in aanloop naar inflatierapport | MT |
14/05 | Transcript : Lonza Group AG, Q1 2024 Earnings Call, May 14, 2024 |
Omzet 2024 * | 6,66 mld. 7,44 mld. 6,93 mld. | Omzet 2025 * | 7,63 mld. 8,52 mld. 7,94 mld. | Marktkapitalisatie | 34,98 mld. 39,11 mld. 36,41 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 893 mln. 998 mln. 929 mln. | Nettowinst (verlies) 2025 * | 1,11 mld. 1,24 mld. 1,15 mld. | EV/omzet 2024 * | 5,66 x |
Nettoschuld 2024 * | 2,72 mld. 3,04 mld. 2,83 mld. | Nettoschuld 2025 * | 3,32 mld. 3,71 mld. 3,45 mld. | EV/omzet 2025 * | 5,02 x |
K/w-verhouding 2024 * |
39,2
x | K/w-verhouding 2025 * |
31,3
x | Werknemers | - |
Dividendrendement 2024 * |
0,93% | Dividendrendement 2025 * |
1,09% | Vrij verhandelbaar | 96,79% |
Recentste transcriptie over Lonza Group AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 25-04-17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 01-12-21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 16-04-14 |
Director/Board Member | 66 | 16-04-14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 05-05-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,81% | 56,61 mld. | |
-7,78% | 39,62 mld. | |
-9,38% | 28,28 mld. | |
+11,48% | 26,44 mld. | |
-17,08% | 20,12 mld. | |
+29,84% | 12,51 mld. | |
+28,01% | 12,48 mld. | |
-0,75% | 12,2 mld. | |
-10,42% | 11,02 mld. |
- Beurs
- Aandelen
- Koers LONN
- Koers